[1]黄昌恒 于耀宇 赵文可 何一川 姚自同.黄芪甲苷对大鼠蛛网膜下腔出血后迟发性脑血管痉挛的影响[J].中国临床神经外科杂志,2019,(02):98-101.[doi:10.13798/j.issn.1009-153X.2019.02.011]
 HUANG Chang-heng,YU Yao-yu,ZHAO Wen-ke,et al.Effect of astragaloside A on delayed cerebral vasospasm in rats after subarachnoid hemorrhage[J].,2019,(02):98-101.[doi:10.13798/j.issn.1009-153X.2019.02.011]
点击复制

黄芪甲苷对大鼠蛛网膜下腔出血后迟发性脑血管痉挛的影响()
分享到:

《中国临床神经外科杂志》[ISSN:1009-153X/CN:42-1603/TN]

卷:
期数:
2019年02期
页码:
98-101
栏目:
论著
出版日期:
2019-02-20

文章信息/Info

Title:
Effect of astragaloside A on delayed cerebral vasospasm in rats after subarachnoid hemorrhage
文章编号:
1009-153X(2019)02-0098-04
作者:
黄昌恒 于耀宇 赵文可 何一川 姚自同
300162 天津,武警后勤学院附属医院神经外科(黄昌恒、于耀宇、赵文可、何一川、姚自同)
Author(s):
HUANG Chang-heng YU Yao-yu ZHAO Wen-ke HE Yi-chuan YAO Zi-tong
Department of Neurosurgery, Affiliated Hospital, Logistics College, Armed Police Command, Tianjin 300162, China
关键词:
蛛网膜下腔出血脑血管痉挛基底动脉黄芪甲苷大鼠
Keywords:
Subarachnoid hemorrhage Astragaloside A Basilar artery Rat
分类号:
R 743.9
DOI:
10.13798/j.issn.1009-153X.2019.02.011
文献标志码:
A
摘要:
目的 探讨黄芪甲苷对大鼠蛛网膜下腔出血(SAH)后迟发性脑血管痉挛的影响及机制。方法 将40只成年雄性SD大鼠随机分为假手术组、黄芪甲苷组(腹腔注射用0.1%二甲基亚砜助溶的黄芪甲苷溶悬液)、模型组和溶媒组(腹腔注射等体积0.1%二甲基亚砜),每组10只。采用颈内动脉刺破法制作SAH模型。SAH后24 h根据改良Garcia神经功能评分评定大鼠神经功能。SAH后6 d,HE染色测量基底动脉横截面积评估血管痉挛,免疫组化染色检测基底动脉p-Akt表达,免疫荧光染色检测基底动脉C-myc和α-SMA表达。结果 与假手术组相比,模型组和溶媒组改良Garcia神经功能评分明显降低(P<0.05),基底动脉横截面积明显减小(P<0.05),基底动脉α-SMA表达水平明显降低(P<0.05),基底动脉p-Akt和C-myc表达水平明显增加(P<0.05);而模型组和溶媒组均无统计学差异(P>0.05)。与溶媒组相比,黄芪甲苷组改良Garcia神经功能评分明显提高(P<0.05),基底动脉横截面积明显增加(P<0.05),基底动脉α-SMA表达水平明显增加(P<0.05),基底动脉p-Akt和C-myc表达水平明显降低(P<0.05)。结论 黄芪甲苷可能通过抑制Akt信号通路下调C-myc的表达、促进α-SMA表达,影响SAH大鼠基底动脉血管平滑肌表型转换和增殖,增加基底动脉横截面积,从而缓解基底动脉痉挛。
Abstract:
Objective To investigate the effect of astragaloside A on the delayed cerebral vasospasm in rats after subarachnoid hemorrhage (SAH). Methods Forty adult male SD rats were randomly divided into sham-operation group, model group, vehicle group (intraperitoneal injection of equal volume 0.1% dimethyl sulfoxide) and astragalin A group (intraperitoneal injection of astragaloside A dissolved in 0.1% dimethyl sulfoxide), with 10 rats in each group. The SAH model was made by the method of internal carotid artery puncture. The neurological function of rats in each group was evaluated by the modified Garcia neurological function score 24 hours after SAH. Six days after SAH, the cross sectional area of basilar artery was measured by HE staining, the expression of p-Akt in basilar artery was detected by immunohistochemical staining, and the expressions of C-myc and alpha smooth muscle actin (α-SMA) in basilar artery were detected by immunofluorescence staining. Results Compared with the sham-operation group, the modified Garcia neurological function scores, the cross sectional areas of basilar artery and the expressions of α-SMA in basilar artery significantly decreased (P<0.05), and the expressions of p-Akt and C-myc in basilar artery significantly increased in model and vehicle groups (P<0.05). There was no statistical difference between model and vehicle groups (P>0.05). Compared with the vehicle group, the modified Garcia neurological function score, the cross sectional area of the basilar artery and the expression level of α-SMA in the basilar artery were significantly increased (P<0.05), and the expression levels of p-Akt and C-myc in basilar artery was significantly decreased in astragalin A group (P<0.05). Conclusion Astragaloside A can relieve the spasm of the basilar artery in rats after SAH by increasing the cross sectional area of the basilar artery which may involve in the inhibition of the Akt signaling pathway.

参考文献/References:


[1] Serrone JC, Hidetsugu M, Mardjono T, et al. Aneurysmal subarachnoid hemorrhage: pathobiology, current treatment and future directions [J]. Expert Rev Neurother, 2015, 15 (4): 367-380.
[2] Angelika E, Christoph S, Johannes W, et al. Molsido mine for the prevention of vasospasm-related delayed ischemic neurological deficits and delayed brain infarction and the improvement of clinical outcome after subarachnoid hemo- rrhage: a single-center clinical observational study [J]. J Neurosurg, 2016, 124(1): 51-58.
[3] 李了了,王 玲,冯 楠,等. 种简单可靠的大鼠蛛网膜下 腔出血模型的建立[J]. 药学学报,2005,40:1096-1098.
[4] Shao A, Guo S, Tu S, et al. Astragaloside Ⅳ alleviates early brain injury following experimental subarachnoid hemo- rrhage in rats [J]. Int J Med Sci, 2014, 11(10): 1073-1081.
[5] Garcia JH, Wagner S, Liu KF, et al. Neurological deficit and extent of neuronal necrosis attributable to middle cerebral artery occlusion in rats [J]. Stroke, 1995, 26(4): 627-635.
[6] Chen CC, Yi-Chou WA, Chen CT, et al. Coadjuvant treat- ment of vasospasm in ruptured unsecured cerebral aneury- sms with aggressive angioplasty, intra-arterial nimodipine, and aneurysm embolization [J]. World Neurosurg, 2018, 116: e452-e459.
[7] Zubkov AY, Tibbs RE, Clower B, et al. Morphological changes of cerebral arteries in a canine double hemorrhage model [J]. Neurosci Lett, 2002, 326(2): 137-141.
[8] Zhang H, Jiang L, Guo Z, et al. PPARβ/δ, a novel regulator for vascular smooth muscle cells phenotypic modulation and vascular remodeling after subarachnoid hemorrhage in rats [J]. Sci Rep, 2017, 7: 45234.
[9] Zhang L, Xu Z, Wu Y, et al. Akt/eNOS and MAPK signaling pathways mediated the phenotypic switching of thoracic aorta vascular smooth muscle cells in aging/hypertensive rats [J]. Physiol Res, 2018, 67(4): 543-553.
[10] Bauer AM, Rasmussen PA. Treatment of intracranial vaso- spasm following subarachnoid hemorrhage [J]. Front Neurol, 2014, 72(5): 1-7.
[11] 赵建伍,于耀宇,余天垒,等. 黄芪甲苷对大鼠蛛网膜下腔 出血后脑血管痉挛的影响[J]. 中国临床神经外科杂志, 2015,20(6):350-352.

相似文献/References:

[1]周路桥 罗富强 彭 虎 邱成元 刘 苏 蒋国辉 田 强 罗荣武.皮瓣塌陷综合征患者颅骨修补术后继发蛛网膜下腔出血1例[J].中国临床神经外科杂志,2015,(11):704.[doi:10.13798/j.issn.1009-153X.2015.11.022]
[2]余龙洋 李亚楠 周 宇 戴冬伟 曹依群 岳志健.垂体腺瘤经蝶术后并发蛛网膜下腔出血的临床分析 (附6例报道)[J].中国临床神经外科杂志,2016,(06):372.[doi:10.13798/j.issn.1009-153X.2016.06.018]
[3]周 量 刘 丛 张昌伟.早期栓塞术治疗动脉瘤性蛛网膜下腔出血的疗效[J].中国临床神经外科杂志,2016,(07):410.[doi:10.13798/j.issn.1009-153X.2016.07.007]
 ZHOU Liang,LIU Cong,ZHANG Chang-wei..Curative effect of early endovascular embolization on patients with ruptured intracranial aneurysms[J].,2016,(02):410.[doi:10.13798/j.issn.1009-153X.2016.07.007]
[4]朱作磊 综述 罗良生 审校.动脉瘤性蛛网膜下腔出血的预后相关因素研究进展[J].中国临床神经外科杂志,2016,(03):183.[doi:10.13798/j.issn.1009-153X.2016.03.020]
[5]廖驭国 刘胜初 钟云天 罗 捷.腰大池引流术防治颅内动脉瘤栓塞术后脑血管痉挛的临床疗效[J].中国临床神经外科杂志,2016,(02):89.[doi:10.13798/j.issn.1009-153X.2016.02.010]
 LIAO Yu-guo,LIU Sheng-chu,CHU Yun-tian,et al.Effect of lumbar cistern drainage on cerebral vasospasm in patients with ruptured intracranial aneurysms after embolization[J].,2016,(02):89.[doi:10.13798/j.issn.1009-153X.2016.02.010]
[6]邹志鹏 杨 海 夏军勇 张化明 张 华 魏 恒 马江红.行血管内治疗的高龄颅内动脉瘤患者脑血管痉挛的临床分析[J].中国临床神经外科杂志,2015,(07):401.[doi:10.13798/j.issn.1009-153X.2015.07.006]
 ZOU Zhi-peng,YANG Hai,XIA Jun-yong,et al.Clinical analysis of symptomatic cerebral vasospasm after endovascular treatment of ruptured cerebral aneurysms in patients of 70 and over 70 years[J].,2015,(02):401.[doi:10.13798/j.issn.1009-153X.2015.07.006]
[7]祝 源 李 俊 陈 刚 向伟楚 李国栋 赵曰圆 李欢欢 汤 伟 金二亮 马廉亭.两次DSA阴性的颅内破裂动脉瘤1例报道并文献复习[J].中国临床神经外科杂志,2015,(09):538.[doi:10.13798/j.issn.1009-153X.2015.09.009]
 ZHU Yuan,LI Jun,CHEN Gang,et al.Both negative DSA findings in 1 patient with ruptured intracranial aneurysm (case report and review of literature)[J].,2015,(02):538.[doi:10.13798/j.issn.1009-153X.2015.09.009]
[8]陈 旭 吴 琳 冯达云 王举磊 秦怀洲 高国栋 张治国.头孢曲松钠对大鼠蛛网膜下腔出血后认知功能的影响[J].中国临床神经外科杂志,2015,(04):228.[doi:10.13798/j.issn.1009-153X.2015.04.012]
 CHEN Xu,WU Lin,FENG Da-yun,et al.Effect of ceftriaxone on cognitive function after subarachnoid hemorrhage in the adult rats[J].,2015,(02):228.[doi:10.13798/j.issn.1009-153X.2015.04.012]
[9]刘骏辉 综述 陈谦学 审校.动脉瘤性蛛网膜下腔出血后抗血管痉挛的药物治疗[J].中国临床神经外科杂志,2016,(08):504.[doi:10.13798/j.issn.1009-153X.2016.08.024]
[10]郎胜坤 许厚银 董月青 马铁柱 孙 艳 郝芊芊 王慧敏.磁共振灌注成像评估蛛网膜下腔出血后脑血管痉挛的价值[J].中国临床神经外科杂志,2016,(09):517.[doi:10.13798/j.issn.1009-153X.2016.09.002]
 LANG Sheng-kuan,XU Hou-yin,DONG Yue-qing,et al.Evaluation of cerebral vasospasm after aneurysmal subarachnoid hemorrhage by magnetic resonance perfusion weighted imaging[J].,2016,(02):517.[doi:10.13798/j.issn.1009-153X.2016.09.002]
[11]旷仁钊 唐晓平 漆 建 苟章洋.丹红注射液对大鼠蛛网膜下腔出血后脑血管痉挛的影响[J].中国临床神经外科杂志,2015,(11):683.[doi:10.13798/j.issn.1009-153X.2015.11.014]
 KUANG Ren-zhao,TANG Xiao-ping,QI Jian,et al.Effects of Danhong on cerebral vasospasm after subara- chnoid hemorrhage in rats[J].,2015,(02):683.[doi:10.13798/j.issn.1009-153X.2015.11.014]
[12]李朝晖 王玉贵 张孟超 综述 赵兴利 审校.CT灌注成像在动脉瘤性蛛网膜下腔出血中的 临床应用进展[J].中国临床神经外科杂志,2016,(05):313.[doi:10.13798/j.issn.1009-153X.2016.05.021]
[13]水 涛 郭再玉 综述 马廉亭 审校.蛛网膜下腔出血后脑血管痉挛的亚低温治疗进展[J].中国临床神经外科杂志,2016,(03):185.[doi:10.13798/j.issn.1009-153X.2016.03.021]
[14]赵建伍 于耀宇 余天垒 李延良 唐 铸 桂 铮 周 欣 姬文婕.黄芪甲苷对大鼠蛛网膜下腔出血后脑血管痉挛的影响[J].中国临床神经外科杂志,2015,(06):350.[doi:10.13798/j.issn.1009-153X.2015.06.010]
 ZHAO Jian-wu,YU Yao-yu,YU Tian-lei,et al.Effects of Astragaloside Ⅳ on delayed cerebral vasospasm after subarachnoid hemorrhage[J].,2015,(02):350.[doi:10.13798/j.issn.1009-153X.2015.06.010]
[15]旷仁钊 综述 唐晓平 审校.蛛网膜下腔出血后脑血管痉挛药物治疗的研究进展[J].中国临床神经外科杂志,2015,(09):572.[doi:10.13798/j.issn.1009-153X.2015.09.024]
[16]赵乐,综述,曹毅,等.尼莫地平在aSAH治疗中的研究进展[J].中国临床神经外科杂志,2017,(02):115.[doi:10.13798/j.issn.1009-153X.2017.02.020]
[17]熊 平 唐晓平.促红细胞生成素对大鼠蛛网膜下腔出血后血管痉挛的防治作用[J].中国临床神经外科杂志,2018,(04):254.[doi:10.13798/j.issn.1009-153X.2018.04.010]
 XIONG Ping,TANG Xiao-ping..Preventive and therapeutic effects of erythropoietin on cerebral vasospasm after subarachnoid hemorrhage in rats[J].,2018,(02):254.[doi:10.13798/j.issn.1009-153X.2018.04.010]
[18]陈华轩 张 渊 王 林 宋旭东 刘 毅 范润金.缺血修饰白蛋白对动脉瘤性蛛网膜下腔出血后脑血管痉挛的评估价值[J].中国临床神经外科杂志,2019,(01):26.[doi:10.13798/j.issn.1009-153X.2019.01.007]
 CHEN Hua-xuan,ZHANG Yuan,WANG Lin,et al.Value of ischemia-modified albumin to assesment of cerebral vasospasm after aneurysmal subarachnoid hemorrhage[J].,2019,(02):26.[doi:10.13798/j.issn.1009-153X.2019.01.007]
[19]谭占国 黄圣明.蛛网膜下腔出血后迟发脑血管痉挛诊治新进展[J].中国临床神经外科杂志,2019,(08):505.[doi:10.13798/j.issn.1009-153X.2019.08.020]
[20]谢昌纪 周志宇 韦成聪.颅内动脉瘤破裂出血后脑血管痉挛发病机制的研究进展[J].中国临床神经外科杂志,2021,26(09):727.[doi:10.13798/j.issn.1009-153X.2021.09.026]

备注/Memo

备注/Memo:
作者单位:300162 天津,武警后勤学院附属医院神经外科(黄昌恒、于耀宇、赵文可、何一川、姚自同)
通讯作者:于耀宇,E-mail:yuyaoyu666@aliyun.com
更新日期/Last Update: 2019-02-20